Intrauterine Misoprostol

DRUG2 trials

Sponsors

Department of Medical Services Ministry of Public Health of Thailand, Self sponsored DR CHIDINMA PEACE OHACHENU

Conditions

Postpartum haemorrhageTo Compare Efficacy Intrauterine vs Sublingual MISOPROSTOL in Addition to Oxytocin in Reducing Blood Loss of Post-cesarean Section in High Risk Women

Phase 2

Randomised Controlled Trial: Intrauterine Misoprostol Versus Sublingual Misoprostol In The Prevention Of Postpartum Hemorrhage At Elective Caesarean Section At Korle Bu Teaching Hospital, Ghana.

Active, not recruitingPACTR202309644870215

Self sponsored DR CHIDINMA PEACE OHACHENUPostpartum haemorrhage

Start: 2023-10-01Target: 148Updated: 2026-01-27

Phase 3

Sublingual vs Intrauterine MISOPROSTOL Plus Oxytocin Infusion for Prevention of Post-cesarean Hemorrhage in High Risk Pregnant Women: A Double-blind Placebo RCT

CompletedNCT04560218

Department of Medical Services Ministry of Public Health of ThailandTo Compare Efficacy Intrauterine vs Sublingual MISOPROSTOL in Addition to Oxytocin in Reducing Blood Loss of Post-cesarean Section in High Risk Women

Start: 2020-10-30End: 2021-09-10Updated: 2021-09-13